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broad-spectrum (MMP-2, -3, -8, -9 and -13) matrix metallo-
proteinase (MMP) inhibitor in the rat meniscal tear model of
Osteoarthritis (OA). In order to assess if MMP-13 was a critical
enzyme responsible for cartilage degradation in this model, a
non-selective MMP inhibitor (MMPI) was compared to a more-
selective inhibitor MMP-13 (MMP-13SI).
Methods: All animal studies were performed at Bolder BioPath
with IACUC approval. Lewis rats were gavaged twice daily with
vehicle, 30 mg/kg MMPI or 30 mg/kg MMP-13SI, starting the
day prior to surgery, with 20 rats per group. Surgery consisted of
sectioning of the medial collateral ligament and medial meniscus.
At 3 weeks post-surgery, plasma was taken for PK analysis, rats
euthanized and the knees harvested for histologic evaluation.
Results: The MMPI gave comparable efficacy to other broad-
spectrum MMP inhibitors, and was consistent across 3 separate
studies. PK analysis showed excellent exposure for both com-
pounds. Despite excellent PK, the MMP-13SI showed no efficacy
in this model.
Conclusions: Several studies using broad-spectrum MMP in-
hibitors (including MMP-13) have shown efficacy in-vivo, but
none have been reported with selective MMP-13 inhibitors. This
is the first published study to show that a more MMP-13 selective
inhibitor, with good PK, was not efficacious in the rat meniscal
tear model of OA.
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Purpose: To evaluate the effect of a polysaccharide derived from
Guar gum (GG) given intra-articularly (i. art.) in joint pain in an
osteoarthritis (OA) model in rats.
Methods: Wistar rats were subjected to ACLT (OA group). Joint
pain was measured using the test for articular incapacitation,
until 7d. The OA group was compared to false-operated (sham).
GG (100μg), gel or solution, or Hylan G-F 20 (100μg) were given
i.art. at day 4 after ACLT and joint pain was recorded daily, until
sacrifice, at day 7. Controls received saline i.art.
Results: Animals of the OA group presented significant joint
pain as compared to sham (P<0.001). GG, either as a gel or
solution, significantly inhibited joint pain. This effect was similar
to the inhibition achieved with Hylan G-F20.
Conclusions: This is the first demonstration that a galactoman-
nan derived from GG is antinociceptive in experimental OA. The
antinociception is independent of the colloidal state. We propose
that the analgesic benefit of viscosupplementation may be due
to an intrinsic carbohydrate-mediated mechanism, rather than to
the rheologic properties of the material.
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Purpose: The purpose of this study was to examine the utility
of using urea concentrations for determining synovial fluid (SF)
joint volume.
Methods: Knee joint SF was collected either directly or by saline
lavage from both knees of 140 human subjects. SF was aspi-
rated directly from 165 knees and by lavage from 110 knees.
No SF was obtainable from 5 joints. Serum was obtained im-
mediately prior to SF aspiration. All participants met ACR and
radiographic (KL grade ≥ 1) criteria for symptomatic OA of at
least one knee. Subjects with knee replacement or bilateral knee
OA of KL grade 4 were excluded. Participants were asked to rate
individual knee pain, aching or stiffness as none, mild, moderate
or severe. SF and serum urea levels were determined using a
specific enzymatic method run on an automated CMA600 ana-
lyzer. Cell counts were performed on direct SF aspirates when
volume permitted. The formula for calculating SF joint volume
was as follows: Vj=CD(VI)/(C-CD) with Vj=volume SF in entire
joint, CD=concentration urea in diluted (lavage) SF, VI=volume
saline injected into joint, and C=concentration urea in undiluted
(neat) SF derived below where C=0.897(Cs), Cs=concentration
urea in serum.
Results: Subject ages ranged from 35-85 years with a mean
of 64 and a median of 66. There was an excellent correlation
(r2=0.8588) between SF and serum urea in the direct aspirates
(Fig. 1) with a ratio of 0.897 (SF/serum). As expected neither
urea levels nor the SF/serum ratio showed any correlation with KL
grade, or cell count. While urea levels increased with age there
was no change in the ratio. Intraarticular SF volumes calculated
for the lavaged knees ranged from 0.555ml to 71.71ml with a me-
dian volume of 3.048ml. There was no correlation of SF volume
to KL grade but there was a positive correlation (p=0.001) be-
tween SF volume and self reported individual knee pain (Fig. 2).
Fig. 1. Correlation of SF and serum urea in direct aspirates.
Fig. 2. Knee joint SF volume by pain.
